Exploring the Binding Interaction of Raf Kinase Inhibitory Protein With the N-Terminal of C-Raf Through Molecular Docking and Molecular Dynamics Simulation

被引:11
作者
Parate, Shraddha [1 ]
Rampogu, Shailima [2 ]
Lee, Gihwan [1 ]
Hong, Jong Chan [1 ]
Lee, Keun Woo [2 ]
机构
[1] Gyeongsang Natl Univ GNU, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Res Inst Nat Sci RINS, Div Life Sci,Div Appl Life Sci BK21 Plus, Jinju, South Korea
[2] Gyeongsang Natl Univ GNU, Plant Mol Biol & Biotechnol Res Ctr PMBBRC, Dept Bio & Med Big Data, Div Life Sci,Res Inst Nat Sci RINS,BK21 4 Program, Jinju, South Korea
基金
新加坡国家研究基金会;
关键词
RKIP; C-Raf; protein-protein docking; HADDOCK; ZDOCK; molecular dynamics simulation; MM; PBSA; binding sites prediction; RKIP BINDING; MAPK PATHWAY; WEB SERVER; IN-SILICO; PREDICTION; HADDOCK; CANCER; POCKET; LIGAND; REGION;
D O I
10.3389/fmolb.2021.655035
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein-protein interactions are indispensable physiological processes regulating several biological functions. Despite the availability of structural information on protein-protein complexes, deciphering their complex topology remains an outstanding challenge. Raf kinase inhibitory protein (RKIP) has gained substantial attention as a favorable molecular target for numerous pathologies including cancer and Alzheimer's disease. RKIP interferes with the RAF/MEK/ERK signaling cascade by endogenously binding with C-Raf (Raf-1 kinase) and preventing its activation. In the current investigation, the binding of RKIP with C-Raf was explored by knowledge-based protein-protein docking web-servers including HADDOCK and ZDOCK and a consensus binding mode of C-Raf/RKIP structural complex was obtained. Molecular dynamics (MD) simulations were further performed in an explicit solvent to sample the conformations for when RKIP binds to C-Raf. Some of the conserved interface residues were mutated to alanine, phenylalanine and leucine and the impact of mutations was estimated by additional MD simulations and MM/PBSA analysis for the wild-type (WT) and constructed mutant complexes. Substantial decrease in binding free energy was observed for the mutant complexes as compared to the binding free energy of WT C-Raf/RKIP structural complex. Furthermore, a considerable increase in average backbone root mean square deviation and fluctuation was perceived for the mutant complexes. Moreover, per-residue energy contribution analysis of the equilibrated simulation trajectory by HawkDock and ANCHOR web-servers was conducted to characterize the key residues for the complex formation. One residue each from C-Raf (Arg398) and RKIP (Lys80) were identified as the druggable "hot spots" constituting the core of the binding interface and corroborated by additional long-time scale (300 ns) MD simulation of Arg398Ala mutant complex. A notable conformational change in Arg398Ala mutant occurred near the mutation site as compared to the equilibrated C-Raf/RKIP native state conformation and an essential hydrogen bonding interaction was lost. The thirteen binding sites assimilated from the overall analysis were mapped onto the complex as surface and divided into active and allosteric binding sites, depending on their location at the interface. The acquired information on the predicted 3D structural complex and the detected sites aid as promising targets in designing novel inhibitors to block the C-Raf/RKIP interaction.
引用
收藏
页数:15
相关论文
共 80 条
  • [21] RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
    Hatzivassiliou, Georgia
    Song, Kyung
    Yen, Ivana
    Brandhuber, Barbara J.
    Anderson, Daniel J.
    Alvarado, Ryan
    Ludlam, Mary J. C.
    Stokoe, David
    Gloor, Susan L.
    Vigers, Guy
    Morales, Tony
    Aliagas, Ignacio
    Liu, Bonnie
    Sideris, Steve
    Hoeflich, Klaus P.
    Jaiswal, Bijay S.
    Seshagiri, Somasekar
    Koeppen, Hartmut
    Belvin, Marcia
    Friedman, Lori S.
    Malek, Shiva
    [J]. NATURE, 2010, 464 (7287) : 431 - U132
  • [22] Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO
  • [23] 2-H
  • [24] Search strategies and evaluation in protein-protein docking: principles, advances and challenges
    Huang, Sheng-You
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (08) : 1081 - 1096
  • [25] Protein-protein docking tested in blind predictions: the CAPRI experiment
    Janin, Joel
    [J]. MOLECULAR BIOSYSTEMS, 2010, 6 (12) : 2351 - 2362
  • [26] Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells
    Janjusevic, Milijana
    Greco, Stefania
    Islam, Md Soriful
    Castellucci, Clara
    Ciavattini, Andrea
    Toti, Paolo
    Petraglia, Felice
    Ciarmela, Pasquapina
    [J]. FERTILITY AND STERILITY, 2016, 106 (06) : 1530 - +
  • [27] Kaczor AA, 2018, METHODS MOL BIOL, V1762, P285, DOI 10.1007/978-1-4939-7756-7_15
  • [28] Kangueane P., 2018, Protein-Protein and Domain-Domain Interactions, P93, DOI DOI 10.1007/978-981-10-7347-2_14
  • [29] Comparative Molecular Docking Analysis of Cytoplasmic Dynein Light Chain DYNLL1 with Pilin to Explore the Molecular Mechanism of Pathogenesis Caused by Pseudomonas aeruginosa PAO
    Kausar, Samina
    Asif, Muhammad
    Bibi, Nousheen
    Rashid, Sajid
    [J]. PLOS ONE, 2013, 8 (10):
  • [30] The role of Raf kinase inhibitor protein (RKIP) in health and disease
    Keller, ET
    Fu, Z
    Brennan, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1049 - 1053